Extended-release naltrexone is associated with a lower rate of opioid relapse than usual treatment among criminal justice offenders, according to a study published in the New England Journal of Medicine.
The Food and Drug Administration (FDA) announced the availability of an investigational test by Roche Molecular Systems to screen blood donations for Zika virus.
Acadia announced that the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted in favor (12-2) that the benefits of Nuplazid (primavanserin) outweighed the risks for the treatment of psychosis associated with Parkinson’s’ disease.
The American College of Cardiology (ACC) and the American Heart Association (AHA) issued updated guidelines for dual antiplatelet therapy in patients with coronary artery disease (CAD).
Researchers from Beth Israel Deaconess Medical Center, Boston, developed a clinical prediction score with modest accuracy in assessing ischemic and bleeding risks with dual antiplatelet therapy following coronary stent placement. Findings from the study are published in JAMA.
Takeda and Lundbeck announced that the FDA has issued a complete response letter for the sNDA regarding the addition of new clinical trial data to the Brintellix (vortioxetine) labeling for treating certain aspects of cognitive dysfunction in adults with major depressive disorder (MDD).
Adherence to a Mediterranean diet is associated with reduced risk of hip fracture, according to a study published online in JAMA Internal Medicine.
Rheumatoid arthritis (RA) patients have a greater prevalence and severity of periodontitis than the non-arthritis population, according to a new study published in the Korean Journal of Internal Medicine.
Patients with Staphylococcus aureus skin and soft tissue infections took an average of 57% of their antibiotic doses after being discharged from the hospital, a new study published in Antimicrobial Agents and Chemotherapy reported.
In a recent study published in Pediatrics, researchers suggested that increased breastfeeding, vaccine administration, and lower rates of smoking may be major factors in the reduced rate of ear infections in babies.
